Enforcement action will be taken against any company marketing the products for children under the age of 3 or who are at low or moderate risk for tooth decay.
Opinion
A sports device to ‘protect the brain’ illustrates a major problem with the FDA de novo pathway
This is not just about one device. It’s about what happens when institutions grow comfortable living in their own ambiguity and hiding behind opacity.” ...
A popular muscle relaxer made in New Jersey is being recalled due to a label swap, according to the FDA. The product was ...
This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key takeaways: You can get semaglutide injections (Ozempic® and Wegovy®) ...
Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn. One of America’s ...
U.S. President Donald Trump's embrace of an old generic drug called leucovorin for use against a rare disorder that causes ...
More than half a million bottles of blood pressure medication are being recalled over a cancer-causing chemical connected to ...
2don MSN
'We don’t have time': Parents of 4-year-old with rare disorder urge FDA to reconsider drug denial
The FDA denied approving DCA to treat a rare disorder called PDCD. The Higbees are urging the agency to reconsider.
Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and immediate adoptability ...
Teasdale Foods Inc. has announced a recall of some of its taco dinner kits due to a labeling error. According to the Food and ...
This recall affects America’s most prescribed drug. It’s the latest in a series of concerning manufacturing issues that have ...
Early data from the ADAPT JR trial suggest efgartigimod may benefit adolescents with generalized myasthenia gravis, a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback